BeStock  
Markets › Compare › STOK vs BRVE

STOK vs BRVE

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
STOK · Stoke Therapeutics$26.81 ▼ 0.45%
BRVE · Braveheart Bio$20.39 ▲ 5.81%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

56698295108Aug 6, '26Sep 29, '26Nov 20, '26
  • STOK -16.0%
  • BRVE -31.6%

Head to head

MetricSTOKBRVE
Price$26.81$20.39
Change today▼ 0.45%▲ 5.81%
Market cap$1.75B$1.83B
Return, 3 months-17.0%-25.9%
Return, year to date-15.5%–
Return, 1 year-8.6%–
P/E (TTM)––
P/B5.03.7
P/E percentile vs own 5y23rd4th
Dividend yield––
Revenue growth (YoY, latest qtr)+5.9%–
Net profit growth (YoY)-92.0%+55.2%
Gross margin––
Operating margin-913.2%–
Net margin-862.1%–
Return on equity-73.6%-13.2%
Analyst target vs. price+80.3%+123.1%
Analyst buy share100%100%
RSI (14)5251
30-day volatility50.0%69.7%
Max drawdown, 1 year-41.3%-41.9%
Trend readLeaning bullishStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • BRVE is the largest of the group by market value.
  • STOK has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top